Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 66 of 120)
- Relevance
  Sort by

Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report

 Report
December 2025
188 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Cardiovascular Drugs - Global Strategic Business Report

 Report
December 2025
413 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Acute Agitation And Aggression Treatment Market Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4406EUR$5,000USD£3,870GBP

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1057EUR$1,200USD£929GBP

€1322EUR$1,500USD£1,161GBP

Cardiomyopathy Therapies - Global Strategic Business Report

 Report
December 2025
227 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pediatric Clinical Trials Market - Global Strategic Business Report

 Report
December 2025
389 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Omics-based Clinical Trials - Global Strategic Business Report

 Report
December 2025
176 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€881EUR$1,000USD£774GBP

€1102EUR$1,250USD£968GBP

CXCR4 Receptor Antagonists - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1057EUR$1,200USD£929GBP

€1322EUR$1,500USD£1,161GBP

T-Cell Lymphoma Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
November 2023
150 Pages
Global

From

€3393EUR$3,850USD£2,980GBP

€4274EUR$4,850USD£3,754GBP

Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
June 2021
193 Pages
Global

From

€4229EUR$4,799USD£3,714GBP

Lung Transplant Rejection - Pipeline Insight, 2025

 Drug Pipelines
April 2025
40 Pages
Global

From

€881EUR$1,000USD£774GBP

€1102EUR$1,250USD£968GBP

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033

 Report
July 2025
150 Pages
Global

From

€5243EUR$5,950USD£4,605GBP

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

 Report
April 2025
125 Pages
Global

From

€5243EUR$5,950USD£4,605GBP

Benign Prostatic Hyperplasia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
97 Pages
Global

From

€3500EUR$4,255USD£3,182GBP

Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

 Report
December 2018
180 Pages
Global

From

€980EUR$1,112USD£861GBP

€1225EUR$1,390USD£1,076GBP

Pancreatic Cancer Drugs Global Market Opportunities and Strategies to 2032

 Report
April 2023
295 Pages
Global

From

€4406EUR$5,000USD£3,870GBP

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025

 Clinical Trials
April 2025
250 Pages
Global

From

€2115EUR$2,400USD£1,858GBP

€2644EUR$3,000USD£2,322GBP

Pharma M&A Deals 2023 - Top Themes - Thematic Research

 Report
January 2024
25 Pages
Global

From

€436EUR$495USD£383GBP

Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Regional Outlook and Forecast, 2023 - 2030

 Report
January 2024
193 Pages
Global

From

€3172EUR$3,600USD£2,786GBP

2,397 Results (Page 66 of 120)
- 1
- 64
- 65
- 66
- 67
- 68

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.